[HTML][HTML] Multifocal hepatocellular carcinoma: a narrative review assessing treatment options from the interventional radiologist's perspective
A Narayanan, A Garza-Berlanga… - Annals of Palliative …, 2023 - apm.amegroups.org
Methods: A narrative literature review of 107 papers was performed in PubMed. Articles from
2010 and newer were used for clinical data and for classification/scoring system details. The …
2010 and newer were used for clinical data and for classification/scoring system details. The …
[PDF][PDF] Outcomes of Liver Resection and Transarterial Chemoembolization in Patients with Multinodular BCLC-A Hepatocellular Carcinoma
Background: This study aimed to compare the outcomes of liver resection (LR) and
transarterial chemoembolization (TACE) in patients with multinodular hepatocellular …
transarterial chemoembolization (TACE) in patients with multinodular hepatocellular …
Selecting the best approach for the treatment of multiple non-metastatic hepatocellular carcinoma
Simple Summary The best therapy for patients with multiple HCC within the Milan Criteria is
liver transplantation (LT). However, LT cannot be offered to all the patients. For the …
liver transplantation (LT). However, LT cannot be offered to all the patients. For the …
[HTML][HTML] Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis
M Risaliti, I Bartolini, C Campani, U Arena… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Hepatocellular carcinoma (HCC) is a common tumour often diagnosed with
a multifocal presentation. Patients with multifocal HCC represent a heterogeneous group …
a multifocal presentation. Patients with multifocal HCC represent a heterogeneous group …
Trans-arterial chemoembolization with degradable starch microspheres (DSM-TACE) versus selective internal radiation therapy (SIRT) in multifocal hepatocellular …
Background To date there is no therapy consensus in patients with multifocal hepatocellular
carcinoma (mHCC). Purpose To compare outcome of trans-arterial chemoembolization …
carcinoma (mHCC). Purpose To compare outcome of trans-arterial chemoembolization …
[HTML][HTML] Resection vs ablation for multifocal hepatocellular carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: a propensity score matching study
W Liu, Z Yang, R Zou, J Qiu, J Shen, Y Liao… - Journal of …, 2019 - ncbi.nlm.nih.gov
With development of surgical technology, we aimed to investigate whether resection could
challenge the standard treatment, ablation, in treating multifocal hepatocellular carcinomas …
challenge the standard treatment, ablation, in treating multifocal hepatocellular carcinomas …
Complex therapeutic strategies for hepatocellular carcinoma: Expanding criteria
E vanSonnenberg, PR Mueller - Radiology, 2019 - pubs.rsna.org
Radiology: Volume 293: Number 3—December 2019 n radiology. rsna. org 717
vanSonnenberg and Mueller radiation therapy and chemotherapy are not particularly …
vanSonnenberg and Mueller radiation therapy and chemotherapy are not particularly …
Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and …
A Takeda, N Sanuki, Y Tsurugai, S Iwabuchi… - Cancer, 2016 - Wiley Online Library
BACKGROUND Curative treatment options for patients with early stage hepatocellular
carcinoma (HCC) include resection, liver transplantation, and percutaneous ablation …
carcinoma (HCC) include resection, liver transplantation, and percutaneous ablation …
Combination transarterial chemoembolization and stereotactic body radiation therapy for unresectable single large hepatocellular carcinoma: results from a …
M Buckstein, E Kim, U Özbek, P Tabrizian… - International Journal of …, 2022 - Elsevier
Purpose Patients with hepatocellular carcinoma (HCC) at Barcelona Clinic Liver Cancer
(BCLC) early-stage A (BCLC A) not suitable for surgery are first considered for ablation …
(BCLC) early-stage A (BCLC A) not suitable for surgery are first considered for ablation …
[HTML][HTML] Transarterial chemoembolization with 125I seed insertion for multifocal hepatocellular carcinoma
YB Wang, Y Zhang, PF Li, L Bao… - Frontiers in Oncology, 2024 - ncbi.nlm.nih.gov
Background A common treatment strategy for individuals with multifocal hepatocellular
carcinoma (HCC) who are not candidates for surgical resection is transarterial …
carcinoma (HCC) who are not candidates for surgical resection is transarterial …